Core Viewpoint - The conference held on August 9 by Guangzhou Pharmaceutical Baiyunshan focused on the latest research breakthroughs of Xingqun Ertian Oil in the field of mosquito repellent and discussed the protection of traditional Chinese medicine heritage culture [1] Group 1 - The conference highlighted the advancements in mosquito repellent research related to Xingqun Ertian Oil [1] - The event included an academic discussion on the protection of intangible cultural heritage related to traditional Chinese medicine [1]

Group 1 - The company activated its emergency response mechanism promptly in response to disaster situations, assessing the needs of affected areas and quickly dispatching targeted medicines [1][2] - In Guizhou's Rongjiang and Sandu, the company completed the preparation and distribution of emergency medicines and supplies worth 500,000 yuan within 48 hours, including 2,750 boxes of Baiyunshan Cold Medicine Granules and 9,600 medical masks [1] - The company provided over 6,500 targeted medicines to Huaihua's Yuanling County in Hunan, demonstrating its commitment to disaster relief efforts [1] Group 2 - The company collaborated with national strategic partners to support flood relief efforts, donating nearly 1 million yuan worth of medicines and supplies to affected areas, military personnel, and veterans [2] - The company emphasized the use of traditional Chinese medicine to build a robust "health barrier" during the disaster response [2]

天眼查商业履历信息显示，广州白云山医药集团股份有限公司，成立于1997年，位于广州市，是一家以 从事医药制造业为主的企业。企业注册资本162579.0949万人民币，实缴资本73230.5103万人民币。公司 法定代表人为李小军。 通过天眼查大数据分析，广州白云山医药集团股份有限公司共对外投资了57家企业，参与招投标项目 491次，知识产权方面有商标信息2450条，专利信息26条，此外企业还拥有行政许可83个。 金融界消息 截至2025年8月8日收盘，白云山（600332）报收于26.68元，下跌0.07%，换手率0.41%，成 交量5.71万手，成交金额1.53亿元。 资金流向方面，今日主力资金净流出1261.69万元，占比成交额8.27%。其中，超大单净流出534.90万 元、占成交额3.51%，大单净流出726.79万元、占成交额4.76%，中单净流出流出87.10万元、占成交额 0.57%，小单净流入1348.79万元、占成交额8.84%。 白云山最新一期业绩显示，截至2025一季报，公司营业总收入224.73亿元、同比减少2.06%，归属净利 润18.21亿元，同比减少6.99%，扣非净利润16.7 ...

来源：新华社 山体滑坡发生后，广州市成立现场指挥部，迅速组织调集精锐专业力量，全力以赴做好抢险救援、伤员 救治、人员转移等各项工作。 截至8月6日17时，白云区共出动应急、消防、公安、住建、卫健、供电、城管、水务等救援力量607人 次，调集生命探测仪、液压扩张器、挖掘机等专业救援设备733台，调集11家医院救护车10车次56人参 与救治，调拨帐篷、雨衣等应急、防疫物资2200份，排查周边区域，妥善做好群众转移工作。 目前，搜救工作仍在紧张进行中。 转自：北京日报客户端 记者从广州市白云区应急管理局获悉，6日8时30分许，由于连日大雨造成山体滑坡，致大源街大源村黄 庄片区房屋受损。截至6日17时，14名被困人员中已救出7名并送医院救治，周边地区996名居民全部转 移安置。 作者: 胡拿云 王瑞平 ...

Group 1 - The article discusses the outbreak of Chikungunya fever, an acute mosquito-borne infectious disease characterized by high fever above 39°C, severe joint pain, and rashes, with no effective vaccine currently available [1] - The National Health Commission has recommended "acetaminophen" as a preferred antipyretic and analgesic to alleviate key symptoms in the "Chikungunya Fever Diagnosis and Treatment Plan (2025 Edition)" [1] - The Foshan Market Supervision Administration has implemented a real-name registration sales system for 47 types of drugs during the epidemic prevention period, including key controlled medicines for managing fever and joint pain [1] Group 2 - Guangzhou Pharmaceutical Group's subsidiary, Baiyunshan, highlighted the value of traditional Chinese medicine products, such as Baiyunshan Cold Medicine Granules, which contain acetaminophen to effectively relieve high fever, headaches, and body aches [2] - Baiyunshan has established GAP (Good Agricultural Practices) bases for the cultivation of medicinal materials, ensuring the safety, quality, and stability of the ingredients used in their products [2] - The sales of mosquito repellent products in Guangzhou, Shenzhen, and Foshan have surged over 200% in the past week, indicating a significant increase in consumer demand for mosquito prevention [3]

文｜证券之星 刘凤茹 近日，白云山公告(600332.SH)拟作为有限合伙人以斥资近15亿元参与设立广州广药基金二期股权投资 合伙企业(有限合伙)(简称"广药基金二期")，后者通过直接或间接的方式开展生物医药领域的股权投 资。白云山此举意在加速布局生物医药健康产业。 证券之星注意到，作为老牌药企，白云山正深陷"2024年归母净利同比下滑三成，创2017年以来新低"的 业绩困局。这背后是明星产品"金戈"销售滑坡、王老吉凉茶式微及对一心堂股权投资计提3.86亿减值的 三锤重击。今年一季度白云山营利双降持续承压，如何走出业绩低谷，是新董事长李小军面临的新课 题。 净利落入七年"谷底"，加速布局生物医药健康 根据公告，广药基金二期的设立结构为：白云山认缴14.985亿元广药基金二期份额，占比99.9%；广州 广药资本私募基金管理有限公司("广药资本")认缴0.015亿元广药基金二期份额，占比0.1%。该基金存续 期为13年，其中投资期10年，退出期3年。 据悉，广药基金二期的管理人为广药资本，后者是白云山控股股东广州医药集团有限公司持股80%的控 股子公司，公司副董事长程宁担任广药资本的董事长。白云山此次认购广药基金 ...

金融界消息 截至2025年8月5日收盘，白云山（600332）报收于26.94元，下跌0.37%，换手率0.66%，成 交量9.21万手，成交金额2.48亿元。 通过天眼查大数据分析，广州白云山医药集团股份有限公司共对外投资了57家企业，参与招投标项目 491次，知识产权方面有商标信息2450条，专利信息26条，此外企业还拥有行政许可83个。 资金流向方面，今日主力资金净流出1420.11万元，占比成交额5.72%。其中，超大单净流出1679.22万 元、占成交额6.76%，大单净流入259.11万元、占成交额1.04%，中单净流出流入68.20万元、占成交额 0.27%，小单净流入1351.90万元、占成交额5.44%。 来源：金融界 白云山最新一期业绩显示，截至2025一季报，公司营业总收入224.73亿元、同比减少2.06%，归属净利 润18.21亿元，同比减少6.99%，扣非净利润16.75亿元，同比减少8.67%，流动比率1.542、速动比率 1.242、资产负债率50.48%。 天眼查商业履历信息显示，广州白云山医药集团股份有限公司，成立于1997年，位于广州市，是一家以 从事医药制造业为主的企业 ...

Group 1 - The establishment of Guangzhou Guangyao Phase II Fund Equity Investment Partnership (Limited Partnership) has been announced, with a total investment of 1.5 billion RMB [1] - The fund is managed by Guangzhou Guangyao Capital Private Fund Management Co., Ltd., focusing on private equity investment, investment management, and asset management activities [1] - Partners in the fund include Baiyunshan (600332) and Guangzhou Guangyao Capital Private Fund Management Co., Ltd. [1]

| 序号 | | 合伙人名称 | 出资比例 ⇒ | | --- | --- | --- | --- | | | (315) | ¯州白云山医药集团股份有限公司 | 99.90% | | | | 国有企业 白云山（600332.SH） 白云山（00874.HK）霞 | | | 2 | | 广州广药资本私募基金管理有限公司 | 0.10% | | | 资本 | 国有企业 执行事务合伙人 私募基金管理人 | | 企查查APP显示，近日，广州广药二期基金股权投资合伙企业（有限合伙）成立，出资额15亿元，经营范围包含：以私募基金从事股权投资、投资管理、资 产管理等活动。企查查股权穿透显示，该企业由白云山（600332）等共同出资。 | . | 广州广 ¯药二期基金股权投资合伙企业（有限合伙 ○ 全国企业信用查询 | | 查一下 | | --- | --- | --- | --- | | 基本信息 7 | 法律诉讼 | 经营风险 | 经营信息 | | 执行事务合伙人 | 广州广 药资本私募基金管理有限 | 登记状态 | 存续（在营、开业、 | | | 公司 | 出资额 | 150000万元 | | 组织机构代码 | MA ...

Core Insights - The article highlights the changes in the Hong Kong Stock Connect holdings, indicating significant increases and decreases in ownership percentages for various companies [1][2]. Group 1: Companies with Increased Holdings - Shandong Molong (00568) saw the largest increase in holdings, up by 7.40%, bringing its total to 61.14% [2]. - Changfei Fiber Optic Cable (06869) experienced a 3.04% increase, with a new holding percentage of 47.11% [2]. - Meizhong Jiahe (02453) had a 2.67% increase, resulting in a holding percentage of 27.92% [2]. - Over the last five trading days, Changfei Fiber Optic Cable (06869) led with a 14.30% increase, now at 47.11% [3]. - Yisou Technology (02550) followed with a 12.39% increase, reaching 58.26% [3]. Group 2: Companies with Decreased Holdings - Baiyunshan (00874) recorded the largest decrease in holdings, down by 0.86%, now at 60.69% [2]. - Huaneng International Power (00902) also decreased by 0.86%, with a holding percentage of 46.50% [2]. - Beijing Capital Machinery (00187) saw a reduction of 0.83%, bringing its total to 46.04% [2]. - In the last five trading days, Shandong Xinhua Pharmaceutical (00719) had the most significant decrease at 3.52%, now at 43.97% [3]. - Asymchem Laboratories (06855) decreased by 2.89%, with a holding percentage of 47.86% [3].